Search

everythinglearnresearchcommunity

for

Search:↓

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

A new method accurately measures long-term hormone levels in hair.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Cyproterone acetate temporarily reduces hair growth in women with idiopathic hirsutism but doesn't change hormone levels.

Finasteride is an effective and well-tolerated treatment for hirsutism.

Chromosomal differences affect how muscle cells respond to testosterone.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Best results found using acetonitrile, water, and trifluoroacetic acid or methanol mixture.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

New compounds may soon be tested to treat excessive hair growth in women.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

New compounds may help treat prostate issues without affecting androgen receptors.

High doses of cyclosporine A increase testosterone conversion, possibly boosting hair growth.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Heart-specific steroid metabolism is crucial in cardiac hypertrophy.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Clascoterone cream could be used for other skin conditions affected by hormones.